Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial-Reference-Cited by-同舟云学术

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Published:2001-09 Issue:9286 Volume:358 Page:958-965
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Manns Michael P,McHutchison John G,Gordon Stuart C,Rustgi Vinod K,Shiffman Mitchell,Reindollar Robert,Goodman Zachary D,Koury Kenneth,Ling Mei-Hsiu,Albrecht Janice K

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999

2. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C;Hepatology,1997

3. Long-term mortality after transfusion associated non-A, non-B hepatitis;Seeff;N Engl J Med,1992

4. Clinical outcomes after transfusion-associated hepatitis C;Tong;N Engl J Med,1995

5. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C;Darby;Lancet,1997

Cited by 5461 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies;Pathogens;2024-09-05

2. Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment;Antimicrobial Agents and Chemotherapy;2024-07-09

3. Cosa deve sapere oggi il pediatra del trattamento dell’epatite C nell’era dei nuovi farmaci antivirali?;Medico e Bambino;2024-05-24

4. Hepatite C: evolução do diagnóstico e tratamento;BEPA. Boletim Epidemiológico Paulista;2024-04-29

5. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective;The Natural Products Journal;2024-04-03